| Synonyms: | |
| Status: | Approved (2019) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | S01LA06 |
| UNII: | XSZ53G39H5 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Vascular endothelial growth factor A inhibitor | Other |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Macular Degeneration | 3 | D008268 | ClinicalTrials |
| Retinal Vein Occlusion | 3 | D012170 | ClinicalTrials |
| Wet Macular Degeneration | 3 | D057135 | ClinicalTrials |
| Macular Edema | 3 | D008269 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1531589-13-5 |
| ChEMBL | CHEMBL3707357 |
| FDA SRS | XSZ53G39H5 |
| Guide to Pharmacology | 8713 |
CONTENTS